Gubra and Camurus Enter into a Collaboration and License Agreement to Develop a Long-acting Treatment for Hypoparathyroidism
Gubra A/S (“Gubra”), a company specialized in peptide-based drug discovery, and Camurus AB (“Camurus”), an international, science-led biopha...
MFN • 16 Dec 11:30